[6-K] BRASKEM SA Current Report (Foreign Issuer)
- None.
- None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2025
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
São Paulo, October 7, 2025.
To
Securities and Exchange Commission of Brazil (CVM)
Att.: Superintendent of Company Relations - SEP
Ref.: Request for clarification regarding news – CVM Process nº 19957.013591/2025-71
Dear Sirs,
We refer to Official Letter nº 255/2025/CVM/SEP/GEA-1 ("Official Letter"), dated October 6, 2025, through which you request clarifications from Braskem S.A. ("Braskem" or "Company"), as detailed below:
“Mr. Director,
1. We refer to the news published today in O Estado de São Paulo, Economy & Business section, under the title: “IG4 wants to take over Braskem in 60 days and banks do not rule out executing guarantee", which contains the following statements:
The creditor banks of Novonor, which controls Braskem, are willing to become shareholders and take control of the petrochemical company in the next 60 days, alongside Petrobras. The Column found that the movement can be carried out even without consensus with Novonor, that is, they do not rule out taking over the shares, which were given as collateral for loans to the former Odebrecht.
2. In view of the above, we require you to clarify whether the news is true and, if so, explain the reasons why it was understood that it is not a Material Fact, in addition to commenting on other information considered important on the matter.”
In this regard, Braskem would like to reiterate that it is not responsible for nor conducts any negotiations by its shareholders, Novonor S.A. – In Judicial Recovery and Petrobras S.A. (“Shareholders”), regarding the potential sale of controlling interest in the Company, nor about possible negotiations by the creditor banks of Novonor S.A. – In Judicial Recovery. In this sense, the Company clarifies that it is not aware of the information contained in such news, which is why it requested clarifications from its Shareholders, who informed the following:
| (A) | Novonor: |
“We received with surprise any mention of a hostile takeover of control of Braskem alongside Petrobras. We also inform that, to date, there has been no material evolution in the discussions it has been holding with interested parties involving its indirect participation in Braskem S.A.”
1
| (B) | Petrobras: |
“The company clarifies that Petrobras does not participate in negotiations between Novonor, banks and IG4. Petrobras reiterates that no decision has been made regarding its participation in Braskem and continues to study alternatives.”
Being what we had to clarify, we made ourselves available to you for any additional clarifications regarding the topic, if necessary.
São Paulo, October 7, 2025.
Felipe Montoro Jens
Chief Financial and Investor Relations Officer
Braskem S.A.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: October 7, 2025
| BRASKEM S.A. | |||
| By: | /s/ Felipe Montoro Jens | ||
| Name: | Felipe Montoro Jens | ||
| Title: | Chief Financial Officer | ||
DISCLAIMER ON FORWARD-LOOKING STATEMENTS
This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.
